Additionally, hyperglycemia, dyslipidemia and the pro-inflammatory state of MetS [14] are plausible stimuli for the synthesis and release of tissue inhibitor of metalloproteinase (TIMP)-1 [15,16]. Here, TIMP1 is linked to metabolic syndrome.